🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective study designed to evaluate the long-term safety and e...
Status
Enrolling By Invitation
Location
Retinal Research Institute, LLC
Start Date
2022-04-04
Trial ID
NCT05296447
Treatments Being Tested
ABBV-RGX-314 (also known as RGX-314 and surabgene lomparvovec (sura-vec)) i...
Status
Active Not Recruiting
Location
Barnet Dulaney Eye Center-Phoenix /ID# 256340
Start Date
2022-01-13
Trial ID
NCT05407636
Treatments Being Tested
ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time...
Status
Active Not Recruiting
Location
Retinal Research Institute /ID# 256019
Start Date
2020-12-29
Trial ID
NCT04704921
Treatments Being Tested
This interventional study is being conducted with an investigational gene t...
Status
Active Not Recruiting
Location
Retinal Research Institute /ID# 255925
Start Date
2020-08-25
Trial ID
NCT04514653
Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, whe...
Status
Recruiting
Location
Retinal Consultants Of Arizona - Phoenix - North /ID# 283407
Start Date
2026-06-01
Trial ID
NCT07592273
Treatments Being Tested
This is a prospective study designed to evaluate the long-term safety and e...
Status
Enrolling By Invitation
Location
Retinal Research Institute, LLC
Start Date
2021-12-20
Trial ID
NCT05210803
Treatments Being Tested
ABBV-RGX-314 is being developed as a novel, potential one-time gene therapy...
Status
Active Not Recruiting
Location
Retinal Research Institute, LLC
Start Date
2020-11-20
Trial ID
NCT04567550